Evolve Gets a Third Medic, Caira, With The New Trailer
2K Gamesand Turtle Rock have revealed the penultimate hunter for Evolve:Caira the Scientist. She is the third Medic in the third set of hunters who you will be able to play as in the game, equipped with healing grenades (that heal allies within their blast radius), napalm grenades and an adrenal boost.
Napalm grenades will give the enemy a light damage persisting in time, while Caira’s adrenal boost gives her and her buddies the ability to move so fast that it is impossible to catch them.
Now it remains one more playable character to be revealed, from the Assault class, and one more monster before Evolver launches on February 10th, 2015for Xbox One, PlayStation 4 and PC. Check out Caira’s trailer below!
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Comments: